Approach to cyanosis (newborn): Clinical sciences

Last updated: January 30, 2025

Approach to cyanosis (newborn): Clinical sciences

Pediatrics

Pediatrics

Approach to acid-base disorders: Clinical sciences
Approach to metabolic acidosis: Clinical sciences
Approach to metabolic alkalosis: Clinical sciences
Approach to respiratory acidosis: Clinical sciences
Approach to respiratory alkalosis: Clinical sciences
Approach to hypernatremia (pediatrics): Clinical sciences
Approach to hypocalcemia (pediatrics): Clinical sciences
Approach to hypoglycemia (pediatrics): Clinical sciences
Approach to hyponatremia (pediatrics): Clinical sciences
Adrenal insufficiency: Clinical sciences
Syndrome of inappropriate antidiuretic hormone secretion: Clinical sciences
Adnexal torsion: Clinical sciences
Appendicitis: Clinical sciences
Approach to abdominal wall and groin masses: Clinical sciences
Approach to dysmenorrhea: Clinical sciences
Cholecystitis: Clinical sciences
Ectopic pregnancy: Clinical sciences
Henoch-Schonlein purpura: Clinical sciences
Inflammatory bowel disease (Crohn disease): Clinical sciences
Inflammatory bowel disease (ulcerative colitis): Clinical sciences
Intussusception: Clinical sciences
Irritable bowel syndrome: Clinical sciences
Pelvic inflammatory disease: Clinical sciences
Testicular torsion (pediatrics): Clinical sciences
Urinary tract infection (pediatrics): Clinical sciences
Approach to anemia (destruction and sequestration): Clinical sciences
Approach to anemia (underproduction): Clinical sciences
Approach to anemia in the newborn and infant (destruction and blood loss): Clinical sciences
Approach to anemia in the newborn and infant (underproduction): Clinical sciences
Approach to leukemia: Clinical sciences
Iron deficiency and iron deficiency anemia (pediatrics): Clinical sciences
Sickle cell disease: Clinical sciences
Approach to bleeding disorders (platelet dysfunction): Clinical sciences
Approach to bleeding disorders (thrombocytopenia): Clinical sciences
Immune thrombocytopenia: Clinical sciences
Meningitis (pediatrics): Clinical sciences
Sepsis (pediatrics): Clinical sciences
Celiac disease: Clinical sciences
Asthma: Clinical sciences
Bronchiolitis: Clinical sciences
Congestive heart failure: Clinical sciences
COVID-19: Clinical sciences
Croup and epiglottitis: Clinical sciences
Cystic fibrosis and primary ciliary dyskinesia: Clinical sciences
Influenza: Clinical sciences
Pneumonia (pediatrics): Clinical sciences
Tuberculosis (pulmonary): Clinical sciences
Upper respiratory tract infections: Clinical sciences
Clostridioides difficile infection: Clinical sciences
Approach to a fever (over 2 months): Clinical sciences
Acute rheumatic fever and rheumatic heart disease: Clinical sciences
Osteomyelitis (pediatrics): Clinical sciences
Otitis media and externa (pediatrics): Clinical sciences
Pharyngitis, peritonsillar abscess, and retropharyngeal abscess (pediatrics): Clinical sciences
Septic arthritis and transient synovitis (pediatrics): Clinical sciences
Stevens-Johnson syndrome and toxic epidermal necrolysis: Clinical sciences
Tuberculosis (extrapulmonary and latent): Clinical sciences
Approach to bacterial causes of fever and rash (pediatrics): Clinical sciences
Acute group A streptococcal infections and sequelae (pediatrics): Clinical sciences
Approach to congenital infections: Clinical sciences
Juvenile idiopathic arthritis: Clinical sciences
Kawasaki disease: Clinical sciences
Lyme disease: Clinical sciences
Periorbital and orbital cellulitis (pediatrics): Clinical sciences
Toxic shock syndrome: Clinical sciences
Staphylococcal scalded skin syndrome and impetigo: Clinical sciences
Approach to a murmur (pediatrics): Clinical sciences
Approach to congenital heart diseases (acyanotic): Clinical sciences
Approach to congenital heart diseases (cyanotic): Clinical sciences
Hypertrophic cardiomyopathy: Clinical sciences
Approach to hepatic masses: Clinical sciences
Hepatitis A and E: Clinical sciences
Hepatitis B: Clinical sciences
Hepatitis C: Clinical sciences
Approach to a limp (pediatrics): Clinical sciences
Approach to a suspected bone tumor (pediatrics): Clinical sciences
Developmental dysplasia of the hip: Clinical sciences
Legg-Calve-Perthes disease and slipped capital femoral epiphysis: Clinical sciences
Approach to peripheral lymphadenopathy (pediatrics): Clinical sciences
Approach to a red eye: Clinical sciences
Approach to vomiting (newborn and infant): Clinical sciences
Acetaminophen (Paracetamol) toxicity: Clinical sciences
Approach to recreational substance exposure (pediatrics): Clinical sciences
Diabetes mellitus (pediatrics): Clinical sciences
Large bowel obstruction: Clinical sciences
Pyloric stenosis: Clinical sciences
Small bowel obstruction: Clinical sciences
Approach to a fever (0-60 days): Clinical sciences
Approach to jaundice (newborn and infant): Clinical sciences
Non-accidental trauma and neglect (pediatrics): Clinical sciences
Necrotizing enterocolitis: Clinical sciences
Neonatal respiratory distress syndrome: Clinical sciences
Approach to respiratory distress (newborn): Clinical sciences
Approach to cyanosis (newborn): Clinical sciences
Approach to shock (pediatrics): Clinical sciences
Approach to lower airway obstruction (pediatrics): Clinical sciences
Approach to upper airway obstruction (pediatrics): Clinical sciences
Anaphylaxis: Clinical sciences
Foreign body aspiration and ingestion (pediatrics): Clinical sciences
Approach to a first unprovoked seizure (pediatrics): Clinical sciences
Febrile seizure (pediatrics): Clinical sciences
Approach to bradycardia: Clinical sciences
Approach to tachycardia: Clinical sciences
Brief, resolved, unexplained event (BRUE): Clinical sciences
Approach to hematochezia (pediatrics): Clinical sciences
Burns: Clinical sciences
Neurogenic shock: Clinical sciences
Approach to delayed puberty: Clinical sciences
Approach to feeding and eating disorders: Clinical sciences
Approach to neurodevelopmental disorders: Clinical sciences
Approach to precocious puberty: Clinical sciences
Approach to short stature: Clinical sciences
Autism spectrum disorder: Clinical sciences
Approach to a child with Down syndrome (trisomy 21): Clinical sciences
Dyslipidemia: Clinical sciences
Essential hypertension: Clinical sciences
Developmental milestones (newborn and infant): Clinical sciences
Developmental milestones (toddler): Clinical sciences
Developmental milestones (childhood): Clinical sciences
Approach to a rash in the well newborn and infant: Clinical sciences
Immunizations (pediatrics): Clinical sciences
Well-child visit (adolescent): Clinical sciences
Well-child visit (newborn and infant): Clinical sciences
Well-child visit (toddler and child): Clinical sciences
Well-patient care (GYN): Clinical sciences
Sports physical (pediatrics): Clinical sciences
Antidiuretic hormone
Body fluid compartments
Movement of water between body compartments
Sodium homeostasis
Acid-base disturbances: Pathology review
Diabetes insipidus and SIADH: Pathology review
Electrolyte disturbances: Pathology review
Renal failure: Pathology review
Acyanotic congenital heart defects: Pathology review
Adrenal masses: Pathology review
Bacterial and viral skin infections: Pathology review
Bone tumors: Pathology review
Coagulation disorders: Pathology review
Congenital neurological disorders: Pathology review
Cyanotic congenital heart defects: Pathology review
Extrinsic hemolytic normocytic anemia: Pathology review
Eye conditions: Inflammation, infections and trauma: Pathology review
Eye conditions: Refractive errors, lens disorders and glaucoma: Pathology review
Headaches: Pathology review
Intrinsic hemolytic normocytic anemia: Pathology review
Leukemias: Pathology review
Lymphomas: Pathology review
Macrocytic anemia: Pathology review
Microcytic anemia: Pathology review
Mixed platelet and coagulation disorders: Pathology review
Nasal, oral and pharyngeal diseases: Pathology review
Nephritic syndromes: Pathology review
Nephrotic syndromes: Pathology review
Non-hemolytic normocytic anemia: Pathology review
Pediatric brain tumors: Pathology review
Pediatric musculoskeletal disorders: Pathology review
Platelet disorders: Pathology review
Renal and urinary tract masses: Pathology review
Seizures: Pathology review
Viral exanthems of childhood: Pathology review
Adrenal insufficiency: Pathology review
Central nervous system infections: Pathology review
Childhood and early-onset psychological disorders: Pathology review
Congenital gastrointestinal disorders: Pathology review
Diabetes mellitus: Pathology review
Environmental and chemical toxicities: Pathology review
Gastrointestinal bleeding: Pathology review
GERD, peptic ulcers, gastritis, and stomach cancer: Pathology review
Inflammatory bowel disease: Pathology review
Medication overdoses and toxicities: Pathology review
Obstructive lung diseases: Pathology review
Pneumonia: Pathology review
Psychiatric emergencies: Pathology review
Shock: Pathology review
Supraventricular arrhythmias: Pathology review
Traumatic brain injury: Pathology review
Ventricular arrhythmias: Pathology review
Congenital TORCH infections: Pathology review
Jaundice: Pathology review
Respiratory distress syndrome: Pathology review
Autosomal trisomies: Pathology review
Cystic fibrosis: Pathology review
Disorders of sex chromosomes: Pathology review
HIV and AIDS: Pathology review
Miscellaneous genetic disorders: Pathology review
Papulosquamous and inflammatory skin disorders: Pathology review
Anxiety disorders, phobias and stress-related disorders: Pathology Review
Developmental and learning disorders: Pathology review
Eating disorders: Pathology review
Mood disorders: Pathology review
Breastfeeding
Pharmacodynamics: Agonist, partial agonist and antagonist
Pharmacodynamics: Desensitization and tolerance
Pharmacodynamics: Drug-receptor interactions
Pharmacokinetics: Drug absorption and distribution
Pharmacokinetics: Drug elimination and clearance
Pharmacokinetics: Drug metabolism
Androgens and antiandrogens
Estrogens and antiestrogens
Miscellaneous cell wall synthesis inhibitors
Protein synthesis inhibitors: Tetracyclines
Cell wall synthesis inhibitors: Penicillins
Antihistamines for allergies
Acetaminophen (Paracetamol)
Non-steroidal anti-inflammatory drugs
Antimetabolites: Sulfonamides and trimethoprim
Antituberculosis medications
Cell wall synthesis inhibitors: Cephalosporins
DNA synthesis inhibitors: Fluoroquinolones
DNA synthesis inhibitors: Metronidazole
Miscellaneous protein synthesis inhibitors
Protein synthesis inhibitors: Aminoglycosides
Bronchodilators: Beta 2-agonists and muscarinic antagonists
Bronchodilators: Leukotriene antagonists and methylxanthines
Pulmonary corticosteroids and mast cell inhibitors
Glucocorticoids
Azoles
Anticonvulsants and anxiolytics: Barbiturates
Anticonvulsants and anxiolytics: Benzodiazepines
Nonbenzodiazepine anticonvulsants

Decision-Making Tree

Transcript

Watch video only

Newborn cyanosis refers to blue or purple skin discoloration that results from poor circulation or inadequate blood oxygenation and indicates a potentially life-threatening condition. Peripheral cyanosis involves the distal extremities only, while central cyanosis also involves the face, trunk, mucous membranes, and tongue. Possible causes of central cyanosis include cyanotic congenital heart disease, pulmonary hypertension, respiratory depression, upper airway obstruction, pulmonary disease, sepsis, and hemorrhagic shock.

Here's a high-yield fact! Acrocyanosis describes bluish-purple discoloration that is isolated to the hands and feet. Unlike central cyanosis, this is a common, transient, and benign finding in the immediate newborn period and is caused by immature vascular tone.

When evaluating a newborn patient with cyanosis, first perform an ABCDE assessment to determine if they are stable or unstable. Newborns with cyanosis are considered unstable, so stabilize their airway, breathing, and circulation; and intubate if needed. Next, obtain IV or IO access, place your patient on continuous vital sign monitoring, and provide supplemental oxygen.

Once you’ve initiated acute management, obtain a focused history and physical exam. The perinatal history might reveal maternal infection or opioid use, meconium-stained amniotic fluid, a complicated birth, or a cesarean or preterm delivery. On physical exam, you’ll notice a blue or purple discoloration of the skin of the extremities and trunk, as well as the mucous membranes and tongue. This finding confirms the presence of central cyanosis. Keep in mind that a visual assessment of cyanosis isn’t always reliable in newborns with deeply pigmented skin, so check areas where the skin is thinnest or has the least amount of pigment, like the oral mucosa, conjunctiva, or nail beds, where cyanosis can sometimes present as grayish-blue!

Now that you’ve identified cyanosis, you should consider the possibility of critical congenital heart disease. Next, obtain pulse oximetry measurements on the right hand, which measures pre-ductal saturation; and either foot, which measures post-ductal saturation. These measurements allow you to compare oxygenation of the systemic circulation before and after the ductus arteriosus inserts into the aorta. If pre-ductal saturations are significantly higher than post-ductal saturations, this means that deoxygenated blood is being shunted from the pulmonary artery to the aorta through an open ductus arteriosus. This is called differential cyanosis and suggests the presence of congenital heart disease.

Next, assess the criteria for performing an echocardiogram. These include an oxygen saturation below 90% in the right hand and foot; an oxygen saturation below 95% in the right hand and foot on three separate occasions; or a difference of 3% or higher between the pre- and post-ductal oxygen saturations on three separate occasions.

Now, if any of these criteria are met, order an echocardiogram to evaluate your patient for congenital heart disease.

Here’s a high-yield fact! If an echocardiogram is unavailable, a hyperoxia test can help distinguish congenital heart disease from pulmonary conditions. To perform this test, obtain arterial blood gases before and after administering 100% oxygen. The PaO2 will rise by 150 mmHg or more after hyperoxia if the newborn has pulmonary disease, but there will be little to no improvement in cyanotic heart lesions with a right-to-left intracardiac shunt.

Let’s discuss newborns with cyanotic congenital heart disease. History might reveal a cardiac defect on prenatal ultrasound or a family history of cyanotic congenital heart disease. The physical exam may demonstrate a murmur, a loud S2, or hepatosplenomegaly. Additionally, the echocardiogram will confirm the presence of a heart defect with a right-to-left intracardiac shunt; and depending on the lesion, there could be pulmonary over or under circulation.

These findings confirm the diagnosis of cyanotic congenital heart disease, which can be categorized according to their characteristic circulatory patterns, including increased or decreased pulmonary blood flow, decreased systemic blood flow, or inadequate pulmonary-systemic mixing. Congenital heart lesions associated with increased pulmonary blood flow include truncus arteriosus and total anomalous pulmonary venous return with obstruction. On the other hand, lesions associated with decreased pulmonary blood flow include tetralogy of Fallot, tricuspid atresia, pulmonary atresia with intact ventricular septum, and Ebstein anomaly. Finally, hypoplastic left heart syndrome is associated with decreased systemic blood flow and signs of shock; while transposition of the great vessels is associated with inadequate pulmonary-systemic mixing.

Here’s another clinical pearl! Heart failure can also cause central cyanosis in the absence of congenital heart defects; for example, conditions like myocarditis and arteriovenous anomalies such as vein of Galen malformation can also be associated with cyanosis.

Let’s move on to persistent pulmonary hypertension of the newborn, which occurs when pulmonary vascular resistance remains elevated after birth. The perinatal history might reveal preterm or cesarean delivery or meconium aspiration, And the exam commonly demonstrates a systolic murmur and loud S2. An echocardiogram will confirm elevated pulmonary artery pressure, with right-to-left shunting at the ductus arteriosus. These findings indicate persistent pulmonary hypertension of the newborn. This condition can be idiopathic, but in some cases, it’s caused by underlying conditions like meconium aspiration syndrome, pneumonia, and neonatal respiratory distress syndrome.

Now let’s switch gears and discuss your steps if the echocardiogram is normal, or if your patient didn’t meet the criteria for an ECHO. In this case, assess your patient’s respirations.

If your patient demonstrates shallow, slow, or absent respirations, consider conditions associated with respiratory depression. The perinatal history might reveal maternal sedative or opioid use, intrauterine distress, or birth trauma. Some newborns may have had postnatal lethargy or seizures, and the exam might demonstrate hypotonia. Next, consider a head ultrasound or CT scan of the head, which might reveal an intracranial hemorrhage. With these findings, diagnose respiratory depression, which can be caused by maternal sedative or opioid use; intrauterine or birth-related asphyxia; hypoxic-ischemic encephalopathy; or intracranial hemorrhage.

Sources

  1. "Updated Strategies for Pulse Oximetry Screening for Critical Congenital Heart Disease" Pediatrics (2020)
  2. "Neonatal Lethargy, Seizures, and Asphyxiation" Pediatr Rev (2017)
  3. "Nelson Textbook of Pediatrics, 21st ed. " Elsevier (2020)
  4. "Congenital Heart Disease" Pediatr Rev (2017)
  5. "Respiratory distress in the newborn" Pediatr Rev (2014)